This in turn suppresses hepatic PPARα-FGF21 signaling and activates the cardiac mechanistic target of rapamycin (mTOR)/ L-type amino acid transporter 1 (LAT1) pathway, contributing to cardiac fibrosis and dysfunction.29 Here, SLC7A5 is linked to fibrosis.